The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A nitrile that is acetonitrile in which one of the hydrogens is replaced by a 4-hydroxyphenyl group while a second hydrogen is replaced by a 4-hydroxybenzyl group. It is a specific agonist for estrogen receptor beta (ERbeta).
2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 mRNA; 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 protein ESR1 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 protein]; ESR2 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 mRNA] 2,3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein]
2,3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [Chlorodiphenyl (54% Chlorine) results in increased activity of CASP3 protein]; 2,3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [perfluorooctane sulfonic acid results in increased cleavage of CASP3 protein]
2,3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of CCND1 protein]; 2,3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [perfluorooctane sulfonic acid results in decreased expression of CCND1 protein]
[2,3-bis(4-hydroxyphenyl)-propionitrile results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of CYP1A1 mRNA
2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR1 protein; ESR1 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 protein]; ESR1 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PDCD4 protein]; ESR1 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PTEN protein]
2,3-bis(4-hydroxyphenyl)-propionitrile results in increased activity of ESR2 protein 2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein; [2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein] which results in increased secretion of Bicarbonates; ESR2 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of SOD2 protein]; ESR2 protein alternative form inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of ESR2 protein] 2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein; 2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [KAT5 protein results in decreased activity of ESR2 protein]; 2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein]; 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased phosphorylation of and results in increased localization of and results in increased activity of ESR2 protein; dicyclohexyl phthalate inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased activity of ESR2 protein]; ESR2 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 mRNA]; ESR2 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PDCD4 mRNA]; Fulvestrant inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased activity of ESR2 protein] 2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein; 2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Estrogens deficiency results in increased expression of ESR2 protein alternative form]; [2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein] inhibits the reaction [Resveratrol results in decreased expression of PRL protein]; [2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein] which results in increased expression of SLC1A2 protein 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of ESR2 mRNA; 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of ESR2 protein; 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of ESR2 protein alternative form 2,3-bis(4-hydroxyphenyl)-propionitrile affects the localization of ESR2 protein ESR2 protein affects the susceptibility to 2,3-bis(4-hydroxyphenyl)-propionitrile 2,3-bis(4-hydroxyphenyl)-propionitrile binds to ESR2 protein
Fulvestrant inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of F11R mRNA]; Fulvestrant inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of F11R protein] 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of F11R mRNA; 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of F11R protein
2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL33 protein]; [2,3-bis(4-hydroxyphenyl)-propionitrile co-treated with Toluene 2,4-Diisocyanate] results in increased expression of IL33 protein [Lipopolysaccharides co-treated with 2,3-bis(4-hydroxyphenyl)-propionitrile] results in increased expression of IL33 protein
2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [KAT5 protein results in decreased activity of ESR2 protein]; 2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein]
2,3-bis(4-hydroxyphenyl)-propionitrile affects the phosphorylation of MAPK1 protein 2,3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [perfluorooctane sulfonic acid results in decreased phosphorylation of MAPK1 protein]
2,3-bis(4-hydroxyphenyl)-propionitrile affects the phosphorylation of MAPK3 protein 2,3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [perfluorooctane sulfonic acid results in decreased phosphorylation of MAPK3 protein]
Fulvestrant inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of OCLN mRNA]; Fulvestrant inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of OCLN protein] 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of OCLN mRNA; 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of OCLN protein
2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PDCD4 protein 2,3-bis(4-hydroxyphenyl)-propionitrile results in decreased expression of PDCD4 mRNA ESR1 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PDCD4 protein]; ESR2 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PDCD4 mRNA]
[4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol co-treated with 2,3-bis(4-hydroxyphenyl)-propionitrile] results in decreased expression of POMC mRNA
[2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein] inhibits the reaction [resveratrol results in decreased expression of PRL protein]
2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PTEN protein ESR1 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PTEN protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of SLC1A2 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of SLC1A2 protein]; [2,3-bis(4-hydroxyphenyl)-propionitrile binds to and results in increased activity of ESR2 protein] which results in increased expression of SLC1A2 protein; Fulvestrant inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of SLC1A2 protein]; RTKI cpd inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of SLC1A2 protein]
2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased activity of SOD2 protein] 2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Glucose results in decreased expression of SOD2 protein]] 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of SOD2 protein ESR2 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of SOD2 protein]
[Lipopolysaccharides co-treated with 2,3-bis(4-hydroxyphenyl)-propionitrile] results in increased secretion of TNF protein 2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] 2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]; Tamoxifen inhibits the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein]]